Literature DB >> 17650509

Rat liver carnitine palmitoyltransferase 1 forms an oligomeric complex within the outer mitochondrial membrane.

Audrey Faye1, Catherine Esnous, Nigel T Price, Marie Anne Onfray, Jean Girard, Carina Prip-Buus.   

Abstract

Carnitine palmitoyltransferase (CPT) 1A catalyzes the rate-limiting step in the transport of long chain acyl-CoAs from cytoplasm to the mitochondrial matrix by converting them to acylcarnitines. Located within the outer mitochondrial membrane, CPT1A activity is inhibited by malonyl-CoA, its allosteric inhibitor. In this study, we investigate for the first time the quaternary structure of rat CPT1A. Chemical cross-linking studies using intact mitochondria isolated from fed rat liver or from Saccharomyces cerevisiae expressing CPT1A show that CPT1A self-assembles into an oligomeric complex. Size exclusion chromatography experiments using solubilized mitochondrial extracts suggest that the fundamental unit of its quaternary structure is a trimer. When studied in blue native-PAGE, the CPT1A hexamer could be observed, however, suggesting that under these native conditions CPT1A trimers might be arranged as dimers. Moreover, the oligomeric state of CPT1A was found unchanged by starvation and by streptozotocin-induced diabetes, conditions characterized by changes in malonyl-CoA sensitivity of CPT1A. Finally, gel filtration analysis of several yeast-expressed chimeric CPTs demonstrates that the first 147 N-terminal residues of CPT1A, encompassing its two transmembrane segments, trigger trimerization independently of its catalytic C-terminal domain. Deletion of residues 1-82, including transmembrane 1, did not abrogate oligomerization, but the latter is limited to a trimer by the presence of the large catalytic C-terminal domain on the cytosolic face of mitochondria. Based on these findings, we proposed that the oligomeric structure of CPT1A would allow the newly formed acylcarnitines to gain direct access into the intermembrane space, hence facilitating substrate channeling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17650509     DOI: 10.1074/jbc.M705418200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Structural insight into function and regulation of carnitine palmitoyltransferase.

Authors:  Arne C Rufer; Ralf Thoma; Michael Hennig
Journal:  Cell Mol Life Sci       Date:  2009-05-09       Impact factor: 9.261

2.  Predicting ovarian cancer recurrence by plasma metabolic profiles before and after surgery.

Authors:  Fan Zhang; Yuanyuan Zhang; Chaofu Ke; Ang Li; Wenjie Wang; Kai Yang; Huijuan Liu; Hongyu Xie; Kui Deng; Weiwei Zhao; Chunyan Yang; Ge Lou; Yan Hou; Kang Li
Journal:  Metabolomics       Date:  2018-04-26       Impact factor: 4.290

3.  Mitochondrial carnitine palmitoyltransferase 1a (CPT1a) is part of an outer membrane fatty acid transfer complex.

Authors:  Kwangwon Lee; Janos Kerner; Charles L Hoppel
Journal:  J Biol Chem       Date:  2011-05-26       Impact factor: 5.157

4.  Self-association of transmembrane domain 2 (TM2), but not TM1, in carnitine palmitoyltransferase 1A: role of GXXXG(A) motifs.

Authors:  Zsuzsanna A Jenei; Karen Borthwick; Victor A Zammit; Ann M Dixon
Journal:  J Biol Chem       Date:  2009-01-09       Impact factor: 5.157

5.  Tissue-based metabolomics reveals potential biomarkers for cervical carcinoma and HPV infection.

Authors:  Abulizi Abudula; Nuermanguli Rouzi; Lixiu Xu; Yun Yang; Axiangu Hasimu
Journal:  Bosn J Basic Med Sci       Date:  2020-02-05       Impact factor: 3.363

6.  Global ubiquitylation analysis of mitochondria in primary neurons identifies endogenous Parkin targets following activation of PINK1.

Authors:  Odetta Antico; Alban Ordureau; Michael Stevens; Francois Singh; Raja S Nirujogi; Marek Gierlinski; Erica Barini; Mollie L Rickwood; Alan Prescott; Rachel Toth; Ian G Ganley; J Wade Harper; Miratul M K Muqit
Journal:  Sci Adv       Date:  2021-11-12       Impact factor: 14.136

7.  L-carnitine is an endogenous HDAC inhibitor selectively inhibiting cancer cell growth in vivo and in vitro.

Authors:  Hongbiao Huang; Ningning Liu; Haiping Guo; Siyan Liao; Xiaofen Li; Changshan Yang; Shouting Liu; Wenbin Song; Chunjiao Liu; Lixia Guan; Bing Li; Li Xu; Change Zhang; Xuejun Wang; Q Ping Dou; Jinbao Liu
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

8.  Fatty acid oxidation promotes reprogramming by enhancing oxidative phosphorylation and inhibiting protein kinase C.

Authors:  Zhaoyu Lin; Fei Liu; Peiliang Shi; Anying Song; Zan Huang; Dayuan Zou; Qin Chen; Jianxin Li; Xiang Gao
Journal:  Stem Cell Res Ther       Date:  2018-02-26       Impact factor: 6.832

Review 9.  SLC22A5 (OCTN2) Carnitine Transporter-Indispensable for Cell Metabolism, a Jekyll and Hyde of Human Cancer.

Authors:  Barbara Juraszek; Katarzyna A Nałęcz
Journal:  Molecules       Date:  2019-12-19       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.